Curis FY26 Q2 net loss widens 71% to $32.78 million vs FY25; revenue posts no revenue vs FY25

• Curis posted a GAAP net loss of $8.58 million for the quarter ended June 30, 2026, essentially unchanged year over year.
• Revenue fell to no revenue from $2.75 million a year earlier after the November 2025 sale of Erivedge ended royalty entitlement.
• Research and development expense slipped 10% to $6.71 million; general and administrative costs eased 9% to $3.23 million.
• Other income swung to $1.36 million from an expense of $342,000, driven by warrant liability fair-value changes tied to the January 2026 PIPE.
• Cash and cash equivalents totaled $5.1 million at June 30; an August 2026 offering added about $4.8 million, funding operations into Q4 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001108205-26-000118), on August 14, 2026, and is solely responsible for the information contained therein.